WallStSmart
MNKD

MannKind Corp

NASDAQ: MNKD · HEALTHCARE · BIOTECHNOLOGY

$3.43
+4.26% today

Updated 2026-10-28

Market cap
$977.50M
P/E ratio
—
P/S ratio
2.48x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$2 – $7
Volume
4.1M

MannKind Corp (MNKD) Insider transactions

Net insider activity
Net buying (6,642,008 shares)
Buy transactions
58
Sell transactions
42

All transactions

DateInsiderTitleTypeSharesPriceValue
2026-03-23TROSS, STUART AChief People & Workpl OfficerBuy221,000——
2026-03-23TROSS, STUART AChief People & Workpl OfficerBuy217,000——
2026-03-23THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy221,000——
2026-03-23THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy217,000——
2026-03-23SINGH, SANJAY REVP Technical OperationsBuy221,000——
2026-03-23SINGH, SANJAY REVP Technical OperationsBuy217,000——
2026-03-23PRENTISS, CHRISTOPHER BChief Financial OfficerBuy221,000——
2026-03-23PRENTISS, CHRISTOPHER BChief Financial OfficerBuy217,000——
2026-03-23CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy796,000——
2026-03-23CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy782,000——
2026-03-23AHUJA, AJAYChief Medical OfficerBuy221,000——
2026-03-23AHUJA, AJAYChief Medical OfficerBuy217,000——
2026-03-10CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy100,000$2.59$259000.00
2026-03-01TROSS, STUART AChief People & Workpl OfficerBuy15,290$3.27$49998.30
2026-03-01SHANNON, JAMES SAMUELDirectorBuy12,000$3.27$39240.00
2026-03-01PRENTISS, CHRISTOPHER BChief Financial OfficerBuy5,000$3.27$16350.00
2026-03-01HOOPER, ANTHONY CDirectorBuy35,000$3.27$114450.00
2026-03-01CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy15,290$3.27$49998.30
2026-02-26TROSS, STUART AChief People & Workpl OfficerBuy28,143——
2026-02-26TROSS, STUART AChief People & Workpl OfficerBuy20,000——
2026-02-26THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy37,525——
2026-02-26THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy20,000——
2026-02-26CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy57,750——
2026-02-26CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy50,000——
2026-02-26CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy37,525——
2026-02-26BINDER, STEVEN B.DirectorBuy45,025——
2026-01-08TROSS, STUART AChief People & Workpl OfficerSale47,006$6.33$297547.98
2025-12-24CASTAGNA, MICHAELDirector, Chief Executive OfficerSale44,171——
2025-12-17CASTAGNA, MICHAELDirector, Chief Executive OfficerSale50,000——
2025-12-17CASTAGNA, MICHAELDirector, Chief Executive OfficerSale15,804——
2025-12-17CASTAGNA, MICHAELDirector, Chief Executive OfficerSale65,804$6.01$395482.04
2025-12-16CASTAGNA, MICHAELDirector, Chief Executive OfficerSale21,310——
2025-12-16CASTAGNA, MICHAELDirector, Chief Executive OfficerSale21,310$6.00$127860.00
2025-12-12CASTAGNA, MICHAELDirector, Chief Executive OfficerSale12,886——
2025-12-12CASTAGNA, MICHAELDirector, Chief Executive OfficerSale7,920——
2025-12-12CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy20,806$4.55$94667.30
2025-12-02THOMSON, DAVIDEVP Genl Counsel & SecretarySale87,780——
2025-12-02THOMSON, DAVIDEVP Genl Counsel & SecretarySale20,000——
2025-12-02THOMSON, DAVIDEVP Genl Counsel & SecretarySale147,780$5.57$823134.60
2025-12-02THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy87,780$4.60$403788.00
2025-12-02THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy60,000$4.55$273000.00
2025-12-02CASTAGNA, MICHAELDirector, Chief Executive OfficerSale65,840——
2025-12-02CASTAGNA, MICHAELDirector, Chief Executive OfficerSale42,080——
2025-12-02CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy107,920$4.55$491036.00
2025-11-14SINGH, SANJAY REVP Technical OperationsSale18,777$5.03$94448.31
2025-11-11AHUJA, AJAYChief Medical OfficerBuy318,200——
2025-10-31SINGH, SANJAY REVP Technical OperationsSale17,071$5.59$95426.89
2025-09-16TROSS, STUART AChief People & Workpl OfficerSale47,000$5.34$250980.00
2025-08-05TROSS, STUART AChief People & Workpl OfficerBuy12,755$3.92$49999.60
2025-07-16THOMSON, DAVIDEVP Genl Counsel & SecretarySale7,466$3.94$29416.04
2025-07-16BINDER, STEVEN B.DirectorSale75,367$3.94$296945.98
2025-07-15TROSS, STUART AChief People & Workpl OfficerSale28,057$3.85$108019.45
2025-07-15THOMSON, DAVIDEVP Genl Counsel & SecretarySale30,361$3.85$116889.85
2025-07-15SINGH, SANJAY REVP Technical OperationsSale15,450$3.85$59482.50
2025-07-15SABELLA, LAUREN MEVP OperationsSale11,896$3.85$45799.60
2025-07-15PRENTISS, CHRISTOPHER BChief Financial OfficerSale11,540$3.85$44429.00
2025-07-15CASTAGNA, MICHAELDirector, Chief Executive OfficerSale111,275$3.85$428408.75
2025-07-15BLANK, BURKHARDEVP Chief Medical OfficerSale9,556$3.85$36790.60
2025-07-15BINDER, STEVEN B.DirectorSale19,383$3.85$74624.55
2025-06-23MARASCO, DOMINICPres, Endocrine Business UnitBuy1,000,000——
2025-06-10BINDER, STEVEN B.DirectorSale64,085$4.00$256340.00
2025-05-27BLANK, BURKHARDEVP Chief Medical OfficerSale15,630$4.12$64395.60
2025-05-20THOMSON, DAVIDEVP Genl Counsel & SecretarySale2,345$4.41$10341.45
2025-05-20BINDER, STEVEN B.DirectorSale12,078$4.40$53143.20
2025-05-19TROSS, STUART AChief People & Workpl OfficerSale6,147$4.37$26862.39
2025-05-19THOMSON, DAVIDEVP Genl Counsel & SecretarySale9,536$4.37$41672.32
2025-05-19CASTAGNA, MICHAELDirector, Chief Executive OfficerSale26,114$4.37$114118.18
2025-05-19BINDER, STEVEN B.DirectorSale5,190$4.37$22680.30
2025-05-14SHANNON, JAMES SAMUELDirectorBuy52,854——
2025-05-14MUNDKUR, CHRISTINEDirectorBuy52,854——
2025-05-14MARASCO, DOMINICPres, Endocrine Business UnitBuy72,500——
2025-05-14MARASCO, DOMINICPres, Endocrine Business UnitBuy59,500——
2025-05-14MARASCO, DOMINICPres, Endocrine Business UnitBuy21,929$4.56$99996.24
2025-05-14KAY, SABRINADirectorBuy52,854——
2025-05-14KAY, SABRINADirectorBuy10,571——
2025-05-14HOOPER, ANTHONY CDirectorBuy52,854——
2025-05-14HOOPER, ANTHONY CDirectorBuy10,571——
2025-05-14HOOPER, ANTHONY CDirectorBuy25,000$4.56$114000.00
2025-05-14GRANCIO, JENNIFERDirectorBuy52,854——
2025-05-14FRIEDMAN, MICHAEL ADirectorBuy52,854——
2025-05-14CONSIGLIO, RONALD JDirectorBuy52,854——
2025-05-14CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy27,000$4.56$123120.00
2025-05-14BINDER, STEVEN B.DirectorBuy52,854——
2025-05-13TROSS, STUART AChief People & Workpl OfficerBuy145,000——
2025-05-13TROSS, STUART AChief People & Workpl OfficerBuy119,000——
2025-05-13THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy145,000——
2025-05-13THOMSON, DAVIDEVP Genl Counsel & SecretaryBuy119,000——
2025-05-13THOMSON, DAVIDEVP Genl Counsel & SecretarySale32,179$4.68$150597.72
2025-05-13SINGH, SANJAY REVP Technical OperationsBuy145,000——
2025-05-13SINGH, SANJAY REVP Technical OperationsBuy119,000——
2025-05-13PRENTISS, CHRISTOPHER BChief Financial OfficerBuy145,000——
2025-05-13PRENTISS, CHRISTOPHER BChief Financial OfficerBuy119,000——
2025-05-13CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy523,000——
2025-05-13CASTAGNA, MICHAELDirector, Chief Executive OfficerBuy428,000——
2025-05-13BINDER, STEVEN B.DirectorSale80,144$4.69$375875.36
2025-05-12TROSS, STUART AChief People & Workpl OfficerSale88,724$4.56$404581.44
2025-05-12TROSS, STUART AChief People & Workpl OfficerSale8,051$4.56$36712.56
2025-05-12THOMSON, DAVIDEVP Genl Counsel & SecretarySale118,473$4.56$540236.88
2025-05-12THOMSON, DAVIDEVP Genl Counsel & SecretarySale12,364$4.56$56379.84
2025-05-12CASTAGNA, MICHAELDirector, Chief Executive OfficerSale334,954$4.56$1.53M

Frequently asked questions

Are MNKD insiders buying or selling?

Over the transactions on record, MNKD insiders have been net buyers, with about $7.01M in stock sold across 42 sales, against 14 open-market purchases.

Does insider selling at MNKD mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which MNKD insiders are selling the most?

Recent selling is concentrated in a few names. CASTAGNA, MICHAEL accounts for the largest share on record, with about $2.59M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.